| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |